Drug Database
Back to search

Ireland· IE-PA-EU/1/24/1794/001

EXBLIFEP 2 g/0.5 g powder for concentrate for solution for infusion

A cefepim und beta-lactamase-inhibitor product containing cefepime dihydrochloride monohydrate + enmetazobactam, registered in Ireland by Advanz Pharma Limited. The same ATC class is registered in 9 of our 19 countries.

ATC J01DE51

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedEXBLIFEP 2 g/0.5 g powder for concent…ATCJ01DE51REGISTER NO.IE-PA-EU/1/24/1794/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cefepime dihydrochloride monohydrate + enmetazobactamAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cefepim und beta-lactamase-inhibitor is registered in 9 of 19 countries.

Countries holding a registration under ATC J01DE51 (cefepim und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose
Search cefepim und beta-lactamase-inhibitor products by name

Cefepim und beta-lactamase-inhibitor · ATC J01DE51

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Cefepime dihydrochloride monohydrate + Enmetazobactam
Manufacturer
Advanz Pharma Limited
Country
Ireland (IE)
ATC code
J01DE51
ATC class
Cefepim und Beta-Lactamase-Inhibitor
Defined daily dose
6 g, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/24/1794/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cefepim und beta-lactamase-inhibitor in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefepim und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Exblifep
  • Liechtenstein · Exblifep
  • Norway · Exblifep

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/956535e3-6d4a-4ec7-8fce-961411285eb2
GET /v1/drugs/956535e3-6d4a-4ec7-8fce-961411285eb2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for concentrate for solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01DE51"
  ],
  "strength": null,
  "pa_number": "EU/1/24/1794/001",
  "substances": [
    "Cefepime dihydrochloride monohydrate",
    "Enmetazobactam"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "21/03/2024",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about cefepim und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console